Gilead Sciences

Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company with a dominant franchise in HIV treatment and prevention, generating billions in annual revenue from drugs like Biktarvy and Descovy. The company is also expanding in oncology through its acquisition of Immunomedics and development of cell therapy treatments. GILD's strong free cash flow supports a growing dividend and aggressive share repurchase program, making it a rare combination of biotech innovation and income generation.

Threads